ACPA levels exceeding 8 U/ml were found in 17.8% of arthritis patients, but not in control subjects (p =.095), without significant correlation to pulmonary anomalies on CXR (p = 1.000). This evidence concerns the gene PRTN3 and arthritic joint disease.